by CyberKnife Miami | Nov 17, 2021 | Best Cancer Doctors, Best CyberKnife Doctors, Cancer Treatment, Lung Cancer
Vaping & Lung Cancer – A Review of Current Data & Recommendations Objectives: Lung cancer is the most common cause of cancer mortality worldwide and, while tobacco smoke remains the primary cause, there is increasing concern that vaping and E-cigarette...
by CyberKnife Miami | Nov 9, 2021 | Lung Cancer, Noninvasive Cancer Treatment
Believe it or not – Lung cancer is one of the most frequently treated types of cancer at the CyberKnife Center of Miami, where we use state-of-the-art radiation called stereotactic body radiation therapy or SBRT to treat lung cancer with precision, less downtime, and...
by CyberKnife Miami | Oct 28, 2021 | CyberKnife Treatment, Lung Cancer, Oligometastatic Cancer
Lung Cancer is a scary diagnosis so you want the best way to treat it and according to the latest research CyberKnife is more efficient, including when there are multiple tumors. Here’s The Full Research Breakdown: Single-Fraction Stereotactic Ablative Body...
by CyberKnife Miami | Oct 26, 2021 | Best Cancer Doctors, Best CyberKnife Doctors, Breast Cancer, Lung Cancer
Research confirms CyberKnife Radiation Therapy Prevents the Risk of developing a Secondary Cancer, Lung Cancer Which can be Caused by Regular Radiation When Treating Breast Cancer. Preventing Lung Cancer Significantly Improves Survival Rates of Breast Cancer Patients....
by CyberKnife Miami | Sep 24, 2021 | Best Cancer Doctors, Lung Cancer
“It started with a pain in Danny’s shoulder. It wasn’t bad but it was persistent and wouldn’t go away so after a couple of weeks I told my husband he better get it checked,” says Melissa Jo Roger. “We live north of Lafayette, Louisiana on a farm with cattle and work...
by CyberKnife Miami | Sep 8, 2021 | Lung Cancer
Yet Another Study Confirms CyberKnife Successfully Treats Lung Cancer Patients Who Are Not Good Candidates for Surgery: Stereotactic body radiotherapy for early-stage non-small cell lung cancer: a multicentre study by the Oncologic Group for the Study of Lung Cancer...
